Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q3 FY26 results · Oct–Dec 2025
Krishna Institute of Medical Sciences reported revenue from operations of ₹997.70 crore (up 29.2% from Q3 FY25) and net profit of ₹51.90 crore (down 43.9% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 997.70 | 772.40 | +29.2% | 960.70 | +3.9% |
| Other income | 5.20 | 17.80 | −70.8% | 4.20 | +23.8% |
| Total income | 1,002.90 | 790.20 | +26.9% | 964.90 | +3.9% |
| Profit before tax | 68.60 | 134.60 | −49.0% | 96.80 | −29.1% |
| Net profit for the period | 51.90 | 92.50 | −43.9% | 72.00 | −27.9% |
| Attributable to shareholders of the company | 53.40 | — | — | 67.10 | −20.4% |
| EPS, basic (₹) | 1.33 | 2.22 | not comparable | 1.67 | not comparable |
| Net margin (%) | 5.2 | 12.0 | 7.5 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 441.90 | 347.50 | +27.2% | 430.00 | +2.8% |
| Other income | 14.30 | 20.60 | −30.6% | 12.50 | +14.4% |
| Total income | 456.20 | 368.10 | +23.9% | 442.50 | +3.1% |
| Profit before tax | 97.80 | 101.90 | −4.0% | 86.10 | +13.6% |
| Net profit for the period | 72.50 | 76.50 | −5.2% | 63.50 | +14.2% |
| EPS, basic (₹) | 1.81 | 1.91 | not comparable | 1.59 | not comparable |
| Net margin (%) | 16.4 | 22.0 | 14.8 |
Consolidated
- Filed with BSE
- 06 Feb 2026, 19:32 IST
- Board meeting
- 06 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Feb 2026, 19:32 IST
- Board meeting
- 06 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE